MicroRNA let-7i 通过直接靶向 IMP2 抑制颗粒黄体细胞增殖和雌二醇生物合成
研究检测多囊卵巢综合征(PCOS)与非 PCOS 女性颗粒黄体细胞(GLC)中 let-7i 表达,并在 KGN 细胞系中用模拟物、抑制剂及 IMP2 慢病毒和 siRNA 做功能实验。结果显示 PCOS GLC 中 let-7i 下调(P=0.001),let-7i 模拟物抑制 KGN 增殖(P=0.001)、降低芳香化酶表达(P=0.030)和雌二醇生成(P=0.029),IMP2 为 let-7i 靶基因且在 PCOS GLC 中上调。结论为 let-7i 通过靶向 IMP2 抑制 KGN 增殖和雌二醇生成。
要点
- PCOS 女性颗粒黄体细胞中 let-7i 表达下调(P=0.001)。
- let-7i 模拟物抑制 KGN 细胞增殖(P=0.001),降低芳香化酶表达(P=0.030)和雌二醇生成(P=0.029)。
- let-7i 直接靶向 IMP2,IMP2 在 PCOS 颗粒黄体细胞中上调(qRT-PCR P=0.001,western blot P=0.044)。
核心结论
- let-7i 在 PCOS 颗粒黄体细胞中下调,过表达 let-7i 以 IMP2 依赖方式抑制 KGN 细胞增殖并减少雌二醇生成,为 PCOS 提供新的分子机制。
研究设计与样本
- 检测 PCOS 与非 PCOS 女性颗粒黄体细胞中 let-7i 表达,并以人颗粒细胞系 KGN 进行功能研究。
- 将 let-7i 模拟物和抑制剂、表达 IMP2 的慢病毒及小干扰 RNA 转染 KGN 细胞。
- 用 EdU 和 CCK-8 法测定 KGN 增殖,PI-annexin V 染色和流式细胞术评估细胞周期与凋亡,酶联免疫法测定雌二醇浓度。
- 采用生物信息学分析和荧光素酶报告实验确认 let-7i 靶基因。
主要发现
- PCOS 颗粒黄体细胞中 let-7i 下调(P=0.001)。
- let-7i 模拟物抑制 KGN 增殖(P=0.001),降低芳香化酶表达(P=0.030)和雌二醇生成(P=0.029),let-7i 抑制剂作用相反。
- 生物信息学分析和 qRT-PCR 确定 IMP2 为 let-7i 靶点(P=0.021)。
- qRT-PCR 和 western blot 显示 PCOS 女性颗粒黄体细胞中 IMP2 上调(P=0.001 和 P=0.044),KGN 细胞中 IMP2 表达被 let-7i 抑制(P<0.001)。
- 荧光素酶报告实验(P=0.002)结合挽救实验证实 let-7i 通过直接靶向 IMP2 抑制 KGN 增殖并降低雌二醇浓度。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Increased granulosa cell division is associated with abnormal folliculogenesis in polycystic ovary syndrome (PCOS). Lethal-7i microRNA (let-7i) may play an important role in the follicular development and granulosa cell growth; therefore is let-7i involved in PCOS pathogenesis? DESIGN: The expression of let-7i was measured in granulosa-luteal cells (GLC) from women with or without PCOS. A human granulosa cell line, KGN, was used for the functional study. Mimics and inhibitors of let-7i, lentiviruses expressing insulin-like growth factor 2 mRNA binding protein (IMP2), and small-interfering RNAs were transfected into KGN cells. KGN cell proliferation was determined by 5-ethynyl-2'-deoxyuridine (EdU) and Cell Counting Kit-8 (CCK-8) assays. The cell cycle and apoptosis were assessed by propidium iodide-annexin V (PI-A) staining and fluorescence-activated cell sorting. Oestradiol concentration was determined by enzyme-linked immunoassay. Bioinformatics analysis and luciferase reporter assay were applied to confirm the let-7i target genes. RESULTS: The study showed that let-7i was down-regulated in PCOS GLC (P = 0.001). Mimics of let-7i inhibited KGN proliferation (P = 0.001), and decreased aromatase expression (P = 0.030) and oestradiol production (P = 0.029), whereas let-7i inhibitors had the opposite effect. Bioinformatics analysis and quantitative real-time (qRT) PCR identified IMP2 as a target of let-7i (P = 0.021). qRT-PCR and western blot analysis indicated that IMP2 was up-regulated in GLC in women with PCOS (P = 0.001 and P = 0.044), and IMP2 expression was suppressed by let-7i in KGN cells (P < 0.001). Luciferase reporter assay results (P = 0.002), combined with the rescue assay, confirmed that let-7i inhibited KGN cell proliferation and reduced oestradiol concentration by directly targeting IMP2. CONCLUSIONS: let-7i was down-regulated in PCOS GLC. Overexpression of let-7i inhibited KGN cell proliferation and decreased oestradiol production in an IMP2-dependent manner, providing a new molecular mechanism for PCOS.
引用
- Xu X, Shen HR, Yu M, et al. MicroRNA let-7i inhibits granulosa-luteal cell proliferation and oestradiol biosynthesis by directly targeting IMP2. Reprod Biomed Online. 2022. PMID: 35339367. doi:10.1016/j.rbmo.2022.01.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。